Epithelial OPA1 links mitochondrial fusion to inflammatory bowel disease
Science Translational Medicine · 15.01.2025 · 17 (781)
DOI: 10.1126/scitranslmed.adn8699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 15.01.2025. Verfasst von Li-Li Bao und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, 91052 Erlangen, Germany. Hauptthemen laut MEDLINE: GTP Phosphohydrolases, Inflammatory Bowel Diseases, Mitochondrial Dynamics, Mitochondria. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Dysregulation at the intestinal epithelial barrier is a driver of inflammatory bowel disease (IBD). However, the molecular mechanisms of barrier failure are not well understood. Here, we demonstrate dysregulated mitochondrial fusion in intestinal epithelial cells (IECs) of patients with IBD and show that impaired fusion is sufficient to drive chronic intestinal inflammation. We found reduced expression of mitochondrial fusion–related genes, such as the dynamin-related guanosine triphosphatase (GTPase) optic atrophy 1 ( OPA1 ), and fragmented mitochondrial networks in crypt IECs of patients with IBD. Mice with Opa1 deficiency in the gut epithelium ( Opa1 i∆IEC ) spontaneously developed chronic intestinal inflammation with mucosal ulcerations and immune cell infiltration. Intestinal inflammation in Opa1 i∆IEC mice was driven by microbial translocation and associated with epithelial progenitor cell death and gut barrier dysfunction. Opa1 -deficient epithelial cells and human organoids exposed to a pharmacological OPA1 inhibitor showed disruption of the mitochondrial network with mitochondrial fragmentation and changes in mitochondrial size, ultrastructure, and function, resembling changes observed in patient samples. Pharmacological inhibition of the GTPase dynamin-1–like protein in organoids derived from Opa1 i∆IEC mice partially reverted this phenotype. Together, our data demonstrate a role for epithelial OPA1 in regulating intestinal immune homeostasis and epithelial barrier function. Our data provide a mechanistic explanation for the observed mitochondrial dysfunction in IBD and identify mitochondrial fusion as a potential therapeutic target in this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, 91052 Erlangen, Germany.
- Department of Ophthalmology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
- Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, 6020 Innsbruck, Austria.
- Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
- iPATH.Berlin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, 10117 Berlin, Germany.
- Deutsches Zentrum Immuntherapie (DZI), 91054 Erlangen, Germany.
ORCID-Profile: Li-Li Bao, Yu-Qiang Yu, Miguel González-Acera, Jay V Patankar, Andreas Giessl, Gregor Sturm, Anja A Kühl, Raja Atreya, Reyes Gámez-Belmonte, Susanne M Krug, Benjamin Schmid, Britta Siegmund, Stefan Wirtz, Michael Stürzl, Mariam Mohamed Abdou, Zlatko Trajanoski, Markus F Neurath, Antonio Zorzano, Christoph Becker
Zitieren
APA
Bao, L. L., Yu, Y. Q., González-Acera, M., Patankar, J. V., Giessl, A., Sturm, G., Kühl, A. A., Atreya, R., Erkert, L., Gámez-Belmonte, R., Krug, S. M., Schmid, B., Tripal, P., Chiriac, M. T., Hildner, K., Siegmund, B., Wirtz, S., Stürzl, M., Mohamed Abdou, M., …, & Becker, C. (2025). Epithelial OPA1 links mitochondrial fusion to inflammatory bowel disease. Science Translational Medicine, 17(781). https://doi.org/10.1126/scitranslmed.adn8699
Vancouver
Bao LL, Yu YQ, González-Acera M, Patankar JV, Giessl A, Sturm G, et al. Epithelial OPA1 links mitochondrial fusion to inflammatory bowel disease. Science Translational Medicine. 2025;17(781). doi:10.1126/scitranslmed.adn8699
BibTeX
@article{Bao2025,
author = {Bao, Li-Li and Yu, Yu-Qiang and González-Acera, Miguel and Patankar, Jay V and Giessl, Andreas and Sturm, Gregor and Kühl, Anja A and Atreya, Raja and Erkert, Lena and Gámez-Belmonte, Reyes and Krug, Susanne M and Schmid, Benjamin and Tripal, Philipp and Chiriac, Mircea T and Hildner, Kai and Siegmund, Britta and Wirtz, Stefan and Stürzl, Michael and Mohamed Abdou, Mariam and Trajanoski, Zlatko and TRR241 IBDome Consortium, TRR241 IBDome Consortium and Neurath, Markus F and Zorzano, Antonio and Becker, Christoph},
title = {Epithelial OPA1 links mitochondrial fusion to inflammatory bowel disease},
journal = {Science Translational Medicine},
year = {2025},
volume = {17},
number = {781},
doi = {10.1126/scitranslmed.adn8699}
}
EUVIMED